#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15608	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2135	726.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1440	1440	C	926	C	858	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15608	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2135	726.7	0	HET	.	.	.	C207T	.	207	207	C	463	463	C	857	C,T	643,154	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28420	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3651	776.5	0	.	n	.	0	T695C	SNP	695	695	T	1096	1096	C	890	C,T	844,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28420	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3651	776.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	2039	2039	G	936	G,A	895,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28420	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3651	776.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2372	2372	C	920	C,T	837,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28420	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3651	776.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2446	2446	A	870	A	827	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28420	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3651	776.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2998	2998	C	850	C	797	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	2016	folP	852	852	99.77	folP.l15.c4.ctg.1	1491	134.5	0	.	p	.	0	A204V	NONSYN	610	612	GCA	887	889	GTA	186;186;186	G;T;A	178;176;177	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	2016	folP	852	852	99.77	folP.l15.c4.ctg.1	1491	134.5	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGC	959	961	AGC	212;213;215	A;G;C	199;197;201	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6318	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3623	174.0	1	SNP	p	S91F	1	.	.	271	273	TTC	714	716	TTC	235;233;235	T;T;C	216;215;219	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6318	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3623	174.0	1	SNP	p	G95N	0	.	.	283	285	GGC	726	728	GGC	226;222;220	G;G;C	208;201;206	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6318	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3623	174.0	1	SNP	p	D95G	1	.	.	283	285	GGC	726	728	GGC	226;222;220	G;G;C	208;201;206	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1758	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1444	121.2	1	SNP	p	G45D	0	.	.	133	135	GGC	511	513	GGC	208;207;206	G;G;C	194;191;190	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	884	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	987	88.9	0	.	n	.	0	A197.	DEL	197	197	A	542	542	A	217	A,C	202,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5788	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3138	183.9	1	SNP	p	D86N	0	.	.	256	258	GAC	628	630	GAC	234;237;235	G;A;C	212;207;216	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5788	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3138	183.9	1	SNP	p	R87W	0	.	.	259	261	CGT	631	633	CGT	233;237;240	C,T;G;T	215,1;216;217	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5788	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3138	183.9	1	SNP	p	R87I	0	.	.	259	261	CGT	631	633	CGT	233;237;240	C,T;G;T	215,1;216;217	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5788	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3138	183.9	1	SNP	p	S87R	1	.	.	259	261	CGT	631	633	CGT	233;237;240	C,T;G;T	215,1;216;217	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5788	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3138	183.9	1	SNP	p	S88P	0	.	.	262	264	TCC	634	636	TCC	242;243;242	T;C;C	222;221;224	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4354	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2454	175.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1464	1466	GGC	231;233;230	G;G;C	216;217;213	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4412	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2337	187.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1225	1227	GCC	220;221;223	G;C;C	210;210;212	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4412	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2337	187.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1228	1230	ATG	224;224;226	A;T;G	207;212;210	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4412	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2337	187.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1240	1242	ACC	235;237;239	A;C;C	218;224;224	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4412	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2337	187.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1240	1242	ACC	235;237;239	A;C;C	218;224;224	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4412	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2337	187.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1741	1743	ACC	222;225;222	A;C;C	204;212;205	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4412	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2337	187.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1795	1797	GCG	202;197;200	G;C;G	190;191;187	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4412	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2337	187.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1795	1797	GCG	202;197;200	G;C;G	190;191;187	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4412	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2337	187.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1918	1920	GGT	203;201;197	G;G;T	189;188;181	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4412	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2337	187.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1927	1929	AGC	181;180;175	A;G;C	169;167;163	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4412	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2337	187.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1945	1947	CCG	167;168;168	C,G;C,G;G	125,2;127,1;130	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6070	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3078	196.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1678	1680	CCG	205;203;203	C;C;G	178;184;175	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2404	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1799	133.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	570	570	C	161	C,T	144,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3042	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1582	190.3	1	SNP	p	G120K	1	.	.	358	360	AAG	632	634	AAG	244;245;246	A;A;G	228;229;224	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3042	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1582	190.3	1	SNP	p	A121N	1	.	.	361	363	AAC	635	637	AAC	249;248;246	A;A;C	228;228;223	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3042	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1582	190.3	1	SNP	p	N121D	0	.	.	361	363	AAC	635	637	AAC	249;248;246	A;A;C	228;228;223	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11182	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4980	224.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1334	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1131	117.2	1	SNP	p	V57M	1	.	.	169	171	ATG	527	529	ATG	271;274;275	A;T;G	261;262;262	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
